Naif Taleb Ali
Journal: BMC pregnancy and childbirth 2025;25(1):722
PMID: 40610949
BACKGROUND
This systematic review (2018-2023) evaluates the diagnostic accuracy of MCV and MPV in pregnancy-related disorders.
OBJECTIVES
Evaluate diagnostic accuracy of MCV/MPV for pregnancy complications.
METHODS
PRISMA 2020 review of 36 studies (2018-2023) using automated analyzers.
RESULTS
- MPV > 10.2 fL predicts preeclampsia (78% sensitivity, AUC 0.81). - MCV < 80 fL indicates iron-deficiency anemia (85% specificity). - MPV > 9.8 fL associates with gestational diabetes (OR 2.3, 95% CI 1.8-3.0). - $0.20/test cost advantage.
CONCLUSION
These low-cost markers could enhance early detection in resource-limited settings. These hematological markers are associated with up to 60% reduction in diagnostic costs when compared to conventional testing methods, making them viable for LMICs.
© 2025. The Author(s).
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.